UK markets close in 3 hours 58 minutes

PCAS SA (0NF7.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
12.88-5.43 (-29.64%)
As of 12:29PM GMT. Market open.

PCAS SA

21, chemin de la sauvegarde
Écully
Longjumeau 69134
France
33 1 69 09 77 85
https://www.pcas.com

Sector(s)
Industry
Full-time employees1,092

Key executives

NameTitlePayExercisedYear born
Mr. Jean-Louis MartinActing CEO & DirectorN/AN/AN/A
Mr. Eric MoissenotGen. Director of Fin. & Admin.N/AN/AN/A
Mr. Gérard GuillamotScientific DirectorN/AN/AN/A
Mr. Christophe Eychenne-BaronHead of R&DN/AN/AN/A
Mr. Sebastien TaillemiteDeputy Managing Director of BU Fine ChemistryN/AN/AN/A
Ms. Juliette MartinChief Exec. Officer of ProtéusN/AN/AN/A
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

PCAS SA develops and produces complex molecules for life sciences and technologies. The company was founded in 1962 and is headquartered in Longjumeau, France. PCAS SA is a subsidiary of Seqens SAS

Corporate governance

PCAS SA’s ISS governance QualityScore as of 1 December 2022 is 10. The pillar scores are Audit: 8; Board: 10; Shareholder rights: 8; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.